Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.
about
Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1Nucleic acid-based approaches to STAT inhibitionStereospecific Effects of Oxygen-to-Sulfur Substitution in DNA Phosphate on Ion Pair Dynamics and Protein-DNA AffinitySTAT6 transcription factor binding sites with mismatches within the canonical 5'-TTC...GAA-3' motif involved in regulation of delta- and mu-opioid receptorsLeukocyte-endothelial cell adhesion: avenues for therapeutic interventionEncapsulation of NF-kappaB decoy oligonucleotides within echogenic liposomes and ultrasound-triggered releaseNeointimal hyperplasia associated with synthetic hemodialysis grafts.Abduction and asylum in the lives of transcription factorsThe impact of molecular medicine upon early cardiovascular drug development.Transcriptional networks in epithelial-mesenchymal transition.Inhibitory effect of nuclear factor-κB decoy oligodeoxynucleotide on liver fibrosis through regulation of the epithelial-mesenchymal transition.SPATA12 and its possible role in DNA damage induced by ultraviolet-C.Therapeutic potential of decoy oligonucleotides strategy in cardiovascular diseases.Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus.Effects of Smad decoy ODN on shear stress-induced atherosclerotic ApoE-/-mouse.Entropic Enhancement of Protein-DNA Affinity by Oxygen-to-Sulfur Substitution in DNA Phosphate.Does gene therapy become pharmacotherapy?Gene therapy imaging in patients for oncological applications.Effects of echinomycin on endothelin-2 expression and ovulation in immature rats primed with gonadotropins.Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease.Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease.First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.Inhibition of tissue factor expression in brain microvascular endothelial cells by nanoparticles loading NF-kappaB decoy oligonucleotides.Pharmacological treatment of abdominal aortic aneurysm.Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity.Subcellular localization as a limiting factor for utilization of decoy oligonucleotides.Dilated cardiomyopathy update: infectious-immune theory revisited.Design and characterization of decoy oligonucleotides containing locked nucleic acids.Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.Transcription factor decoy: a pre-transcriptional approach for gene downregulation purpose in cancer.Transcription factor decoy against stem cells master regulators, Nanog and Oct-4: a possible approach for differentiation therapy.The -786C/T single-nucleotide polymorphism in the promoter of the gene for endothelial nitric oxide synthase: insensitivity to physiologic stimuli as a risk factor for rheumatoid arthritis.Sp1-like activity mediates angiotensin-II-induced plasminogen-activator inhibitor type-1 (PAI-1) gene expression in mesangial cells.Effects of chimeric decoy oligodeoxynucleotide in the regulation of transcription factors NF-κB and Sp1 in an animal model of atherosclerosis."Decoy" of androgen-responsive element induces apoptosis in LNCaP cells.Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits.In vivo transfection of a cis element 'decoy' against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity.A novel WRKY transcription factor, SUSIBA2, participates in sugar signaling in barley by binding to the sugar-responsive elements of the iso1 promoter.Interleukin-10 induction of nitric-oxide synthase expression attenuates CD40-mediated interleukin-12 synthesis in human endothelial cells.
P2860
Q24317649-EF883C7A-FCCB-4422-B8D0-384E99F0A3B1Q26822830-5F0318EF-022C-4810-8A14-5F7D7A51CEE9Q27708987-89C9D3A1-031A-4B16-94EE-9979AD46952CQ28570977-CDE31F72-7F41-471F-AF78-D585E726ED48Q29544231-7C16B01D-A8B2-4350-857A-845F9939A1D8Q30475079-46BA7A0E-7B19-46B2-8FA2-36EE7846B57FQ30492883-C92BC789-8EBA-47B0-B9E3-FA329BA0F9A6Q33732793-DE14E27B-EDF5-4064-8331-E25A2A45AEE5Q33962018-E8CF6A89-72CD-4CFA-8F07-0B5226295083Q34043126-D5F2FFCC-9E5A-42E4-B52D-80D61D2C8CC3Q34063617-251CCF1E-C5A9-4DFE-929F-5466406B7E95Q35036196-F598C4F6-5122-4A2E-9673-6A1EB08B9ADEQ35696375-289E1D29-AEEC-4252-8FFE-BE94D1CCBB80Q35707198-5CFAE6F1-C0DE-4538-B665-BB4E817C6CB2Q35741094-E8098BEC-7C7B-4403-9596-2D610E133D11Q36043829-B89D7D23-0879-4754-894C-7306469C8CE1Q36075155-77395838-B636-4A65-ACCB-2868D9367351Q36265644-202950D7-A90B-473E-B6B0-0F3D6E584325Q36374502-08C8EE68-2094-401F-8391-6494F7BE323CQ36375200-01185879-D938-4686-A2C6-A5B910261311Q36769959-87AFD9EF-C916-4C01-A289-46B0D8F87C39Q36890491-C33DB7DC-6AAE-4E7D-A728-255CC984731FQ37083517-6D49F739-A4B4-42BA-8B2B-7CF1C694A67CQ37489199-766B9B77-684A-4E21-AE6C-DB0AA7A34BE4Q37520915-47D230CD-BD98-43C5-9D9F-33C0A3D7CC7FQ37619688-72CF0212-9AE0-4CAF-9973-7DAC0FA47B0DQ38124734-C80BA2CE-62A6-49C7-A809-783C1F439E9CQ38288803-16E86FF5-A668-4AD0-A5B4-42827257E504Q38290291-960EAD92-CFB6-4A15-B10C-D5F2D01ACA52Q38299475-0EEEA20B-BDD8-4501-B073-88BED8EFFDDEQ38300047-2AF53990-8C26-4DC0-B537-CDEF0066B847Q38302569-A1FCAAC6-C6EE-4873-B625-6C1C5E656CEAQ38309060-089AFF89-980A-4868-B196-D455F869A87BQ38310792-E44CE58D-3FD6-43F7-80B7-A6664C03EAECQ38320407-8E4CFEFD-287B-4623-810C-7C013D7CBBACQ38320830-404E95CB-C8A9-4559-AC99-691805F4A4F1Q38326406-B50B9258-FB31-487A-9A8A-071930CBF067Q38337831-74658F16-5291-4E7B-88DA-1BF87E94D555Q38350841-8FA8006C-053E-4B6C-911E-10BF8501FFB8Q38352602-E12A33F4-8DB9-48FF-8306-7A6827D41D07
P2860
Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Application of transcription f ...... ion in cardiovascular disease.
@en
Application of transcription f ...... ion in cardiovascular disease.
@nl
type
label
Application of transcription f ...... ion in cardiovascular disease.
@en
Application of transcription f ...... ion in cardiovascular disease.
@nl
prefLabel
Application of transcription f ...... ion in cardiovascular disease.
@en
Application of transcription f ...... ion in cardiovascular disease.
@nl
P2093
P1433
P1476
Application of transcription f ...... ion in cardiovascular disease.
@en
P2093
P304
P356
10.1161/01.RES.82.10.1023
P577
1998-06-01T00:00:00Z